Table 2 |
|||
|
Association of autoantibodies with shared epitope (SE) alleles |
|||
| SE/x |
SE/SE |
*0401/*0101 |
|
|
|
|||
| All patients |
|||
| RF |
1.8 |
3.7* |
8.7* |
| AFA |
2.2* |
5.1* |
9.5* |
| Anti-Sa |
2.0 |
7.1* |
18.9* |
| Anti-CCP |
2.0 |
5.0* |
10.9* |
| AKA |
1.4 |
3.1* |
3.4* |
| RA patients |
|||
| RF |
1.8 |
2.7 |
5.3 |
| AFA |
2.2 |
4.9* |
6.5* |
| Anti-SA |
1.9 |
4.0* |
10.6* |
| Anti-CCP |
2.0 |
3.0 |
7.2* |
| AKA |
1.4 |
2.9 |
3.3 |
|
|
|||
|
Numbers represent odds ratios for having each autoantibody associated with shared epitope alleles. SE/x, SE/SE, DRB *0401/*0101 were each compared with patients with no shared epitope alleles. *P<0.05 by Chi-square after Bonferroni adjustment for multiple comparison, RF, Rheumatoid factor; AFA, antifilaggrin antibody; CCP, cyclic citrullinated peptide; AKA, antikeratin antibody. |
|||
|
Goldbach-Mansky et al. Arthritis Res 2000 2:236 doi:10.1186/ar93 |
|||